(Q33744876)

29 July 2017

1 reference

title

Adenovirus vectors for gene delivery (English)

1 reference

Michel Jean Robert Perricaudet

29 July 2017

1 reference

series ordinal

object named as

Perricaudet M

1 reference

29 July 2017

Benihoud K

1 reference

29 July 2017

Yeh P

series ordinal

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Current Opinion in Biotechnology

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

440-447

1 reference

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Widespread long-term gene transfer to mouse skeletal muscles and heart

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Recombinational construction in Escherichia coli of infectious adenoviral genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Oncogenic potential of the adenovirus E4orf6 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Persistence in muscle of an adenoviral vector that lacks all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Adenoviral vectors for gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Adenovirus-Mediated Gene Transfer of Viral Interleukin-10 Inhibits the Immune Response to Both Alloantigen and Adenoviral Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Circumvention of immunity to the adenovirus major coat protein hexon.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Role of early region 3 (E3) in pathogenesis of adenovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Targeted gene delivery by tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

A system for the propagation of adenoviral vectors with genetically modified receptor specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Adenovirus-mediated regulable target gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900007-5

7 January 2021

10.1016/S0958-1669(99)00007-5

Identifiers

DOI

1 reference

29 July 2017

1 reference